Listeria monocytogenes is a foodborne pathogen that disproportionally affects pregnant females, older adults, and immunocompromised individuals. Using U.S. Foodborne Diseases Active Surveillance Network (FoodNet) surveillance data, we examined listeriosis incidence rates and rate ratios (RRs) by age, sex, race/ethnicity, and pregnancy status across three periods from 2008 to 2016, as recent incidence trends in U.S. subgroups had not been evaluated. The invasive listeriosis annual incidence rate per 100,000 for 2008?2016 was 0.28 cases among the general population (excluding pregnant females), and 3.73 cases among pregnant females. For adults ? 70 years, the annual incidence rate per 100,000 was 1.33 cases. No significant change in estimated listeriosis incidence was found over the 2008?2016 period, except for a small, but significantly lower pregnancy-associated rate in 2011?2013 when compared with 2008? 2010. Among the nonpregnancy-associated cases, RRs increased with age from 0.43 (95% confidence interval: 0.25? 0.73) for 0- to 14-year olds to 44.9 (33.5?60.0) for ? 85-year olds, compared with 15- to 44-year olds. Males had an incidence of 1.28 (1.12?1.45) times that of females. Compared with non-Hispanic whites, the incidence was 1.57 (1.18?1.20) times higher among non-Hispanic Asians, 1.49 (1.22?1.83) among non-Hispanic blacks, and 1.73 (1.15? 2.62) among Hispanics. Among females of childbearing age, non-Hispanic Asian females had 2.72 (1.51?4.89) and Hispanic females 3.13 (2.12?4.89) times higher incidence than non-Hispanic whites. We observed a higher percentage of deaths among older patient groups compared with 15- to 44-year olds. This study is the first characterizing higher RRs for listeriosis in the United States among non-Hispanic blacks and Asians compared with non-Hispanic whites. This information for public health risk managers may spur further research to understand if differences in listeriosis rates relate to differences in consumption patterns of foods with higher contamination levels, food handling practices, comorbidities, immunodeficiencies, health care access, or other factors.